1-[1-(2,6-difluorophenyl)-1H-pyrazol-3-yl]methanamine hydrochloride, 95.0%, 250mg

2-(Benzyl(cyclopropylmethyl)amino)ethanol, 95.0%, 25g

Dimethyl-{6-[3-(methyl-hydrazonomethyl)-phenyl]-4-trifluoromethyl-pyridin-2-yl}-amine, 95.0%, 1g

Sodium 4-Hydroxybenzenesulfonate Dihydrate>98.0%(HPLC)(T)500g

1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester, 98%, 5g

(R)-5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 97%, 1g

1-(6-Bromo-pyridin-2-yl)-azetidine-3-carboxylic acid, 95.0%, 100mg

TERT-BUTYL 2-CYCLOPROPYLHYDRAZINECARBOXYLATE, 95.0%, 100mg

1,1-Difluoro-propan-2-one, 95%, 5g

Sodium hydrogen sulphite solution, min. 37%, in water, 1 l, plastic packaging.

3-Methyl-1H-indazol-6-ylamine, 95.0%, 1g

4-Methylpiperidine-4-carbonitrile hydrochloride, 95.0%, 1g

4-Chloro-1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline, 95.0%, 10g